Research
Online Inquiry

5-Bromo-2'-deoxyuridine (BrdU)

Cat.No: RESK-0503 Datasheet

Quantities:
- +
Product Details Related Products
Product Name 5-Bromo-2'-deoxyuridine (BrdU)
Catalog No. RESK-0503
Description 5-Bromo-2'-deoxyuridine (BrdU; CAS No. 59-14-3) is a synthetic thymidine analog and one of the commonly used cell proliferation markers, alongside DNA polymerase alpha, proliferating cell nuclear antigen (PCNA) and Ki-67. Because BrdU is not endogenously expressed in tissue cells, it has relatively broad applications. Synonyms: Br-dU; BUdR; 5-BrdU; 5-Bromodeoxyuridine. During S phase, BrdU selectively incorporates into cellular DNA in place of thymidine, enabling the detection of DNA synthesis and the labeling of cell division, apoptosis and related behaviors. In genetic research, BrdU can be administered by in vivo injection or loaded through cell culture, followed by specific labeling with an anti-BrdU monoclonal antibody and ICC or IHC staining to visualize proliferating cells. It can also be combined with other cell markers for double staining to determine the type and proliferation rate of proliferating cells, which is of great significance for the study of cell kinetics.
Intended Use Labeling and detection of cell proliferation, DNA synthesis, cell division and apoptosis in tissue and cultured cells by ICC or IHC with an anti-BrdU monoclonal antibody; suitable for in vivo injection or cell culture loading; can be combined with other cell markers for double staining in cell kinetics studies.
Principle / Technology BrdU is a synthetic thymidine analog that is selectively incorporated into cellular DNA in place of thymidine during S phase. Incorporated BrdU is detected by specific immunolabeling with an anti-BrdU monoclonal antibody, visualizing proliferating cells via ICC or IHC staining.
Detection Method Immunostaining (ICC or IHC) with an anti-BrdU monoclonal antibody; double staining with other cell markers is possible.
Sample Type Cultured cells and animal tissues (including frozen sections), loaded by cell culture or in vivo injection.
Performance Range / Specifications Appearance: white or off-white powder
Purity (HPLC): >=99%
Molecular weight: 307.10
Melting point: 187-189 °C
CAS No.: 59-14-3
Formula: C9H11BrN2O5
Solubility: soluble in 1 M ammonium hydroxide (50 mg/mL) and water (up to 10 mg/mL); soluble in DMF, DMSO and water with heating (50-100 mg/mL)
Specificity Selectively incorporated into cellular DNA in place of thymidine during S phase; detected specifically with an anti-BrdU monoclonal antibody. BrdU is not endogenously expressed in tissue cells.
Reaction Conditions / Protocol 1. Load BrdU by in vivo injection or through cell culture.
2. Warm at 37 °C as needed for use.
3. Before blocking, treat samples with 2 N HCl for 1 h to denature the DNA double strands and expose the BrdU epitope; wash away the HCl.
4. Neutralize with an equal volume of 0.1 M Na2B4O7 for 15 min at room temperature, then wash away the sodium tetraborate.
5. Block and perform immunostaining with an anti-BrdU monoclonal antibody and the appropriate secondary antibody (ICC or IHC).
Components / Formulation Single-reagent powder (white or off-white). Formula: C9H11BrN2O5.
Storage Conditions Store at -25 to -15 °C in a dry place.
Shelf Life 2 years when stored as directed.
Package Specifications 100 mg
1 g
5 g
Product Form White or off-white powder.
Quality Control Purity verified by HPLC (>=99%).
Purity >=99% (HPLC)
Molecular Weight 307.10
Shipping Conditions Shipped with ice packs.
Expiration Date / Stability Stable for 2 years when stored dry at -25 to -15 °C.
Regulatory / Compliance For research use only.
Compatibility Can be combined with other cell markers for double staining to determine the type and proliferation rate of proliferating cells.
Recommended Buffer System Soluble in 1 M ammonium hydroxide (50 mg/mL) and water (up to 10 mg/mL); soluble in DMF, DMSO and water with heating (50-100 mg/mL).
Application Notes / Precautions 1. Heating at 37 °C is required for use.
2. For BrdU staining of frozen sections, nonspecific staining throughout the section with cytoplasmic signal may result from incomplete perfusion, leaving red blood cells in the tissue; ensure thorough perfusion and control the color development time.
3. If no fluorescent signal is obtained after primary and secondary antibody staining of animal or cell samples: before blocking, treat with 2 N HCl for 1 h to denature the DNA double strands and fully expose BrdU, then wash; neutralize with an equal volume of 0.1 M Na2B4O7 for 15 min at room temperature and wash away the sodium tetraborate. Without neutralization, the acidification will reduce subsequent antibody titers, resulting in poor or failed staining.

For research use only, not for clinical use.

0
0

There is no product in your cart.